# GENSIGHT BIOLOGICS S.A. — Form D

GENSIGHT BIOLOGICS S.A. of Paris, I0, a company, filed a Form D exempt-offering notice with the SEC on 2015-07-08. The offering totals $25.0M, of which $25.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2015-07-08
- Form: D
- Accession: 0001209191-15-060045
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $25.0M
- Amount sold: $25.0M
- Investors: 15
- Date of first sale: 2015-07-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-243245

## Issuer

- Name: GENSIGHT BIOLOGICS S.A.
- CIK: 0001641634
- Entity type: Corporation
- Jurisdiction: FRANCE
- Incorporated: 2012
- Address: 74 rue du Faubourg Saint-Antoine, Paris, I0, 75012
- Phone: 01133176217220

## Officers, directors & promoters (11)

| Name | Role | Location |
| --- | --- | --- |
| Bernard Gilly | Director | Paris, I0 |
| Peter Goodfellow | Director | Paris, I0 |
| Florent Gros | Director | Menlo Park, CA |
| GENGHIS LLOYD-HARRIS | Director | LONDON, X0 |
| Guido Magni | Director | Watertown, MA |
| Michael Stephen Wyzga | Director | Paris, I0 |
| Jean-Philippe Combal | Executive Officer | Paris, I0 |
| Thomas Gidoin | Executive Officer | Paris, I0 |
| Bernard Gilly | Executive Officer | Paris, I0 |
| Didier Pruneau | Executive Officer | Paris, I0 |
| Nitza Thomasson | Executive Officer | Paris, I0 |

## More

- [CIK 1641634 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1641634&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001209191-15-060045.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.